High CD34 cell doses do not worsen regimen-related toxicity or early mortality after autologous blood stem cell transplantation for breast cancer

Author: Braunschweig I.   Mirza N.Q.   Rondon G.   Lauppe J.   Mehra R.   Gajewski J.   Körbling M.   Huh Y.O.   Geisler D.   Gee A.P.   Champlin R.   Przepiorka D.  

Publisher: Ashgate Publishing Ltd

ISSN: 1465-3249

Source: Cytotherapy, Vol.2, Iss.2, 2000-02, pp. : 105-110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content